Hoffmann-La Roche, Inc. | Roche | employment discrimination | 2012 | private lawsuit-federal | $545,833 |
Sanofi-Aventis U.S. LLC | Sanofi | employment discrimination | 2010 | private lawsuit-federal | $15,360,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2008 | private lawsuit-state | $350,000 |
General Nutrition Corporation | Harbin Pharmaceutical Group | employment discrimination | 2019 | private lawsuit-federal | $550,187 |
Merck & Company, Inc. | Merck | employment discrimination | 2019 | OFCCP | $289,755 |
Imclone Systems, Inc. | Eli Lilly | employment discrimination | 2005 | EEOC | $85,000 |
Merck & Co. Inc. | Merck | employment discrimination | 2019 | private lawsuit-federal | $6,200,000 |
IDEXX Laboratories, Inc. | IDEXX Laboratories | employment discrimination | 2020 | OFCCP | $200,000 |
Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | employment discrimination | 2020 | OFCCP | $379,089 |
Perrigo Company | Perrigo | employment discrimination | 2021 | NY-NYCCHR | $20,000 |
GNC | Harbin Pharmaceutical Group | employment discrimination | 2019 | NY-NYCCHR | $35,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2021 | OFCCP | $560,000 |
Pfizer Inc. | Pfizer | employment discrimination | 2023 | OFCCP | $2,500,000 |
EMD Chemicals, Inc. | Merck KGaA (EMD) | economic sanction violation | 2007 | OFAC | $8,250 |
Chiron Corporation Ltd | Novartis | economic sanction violation | 2004 | OFAC | $168,500 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | economic sanction violation | 2004 | OFAC | $6,600 |
Fort Dodge Animal Health | Zoetis | economic sanction violation | 2004 | OFAC | $26,956 |
ICN Pharmaceuticals, Inc | Bausch Health | economic sanction violation | 2004 | OFAC | $5,500 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
Genzyme Corporation | Sanofi | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
McNeil-PPC Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2015 | FDA | $25,000,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
Ranbaxy USA Inc. | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals | Endo International | drug or medical equipment safety violation | 2015 | USAO | $39,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
GNC Holdings Inc. | Harbin Pharmaceutical Group | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | drug or medical equipment safety violation | 2017 | DOJ_CIVIL | $35,000,000 |
Schering-Plough Corporation | Merck | drug or medical equipment safety violation | 2002 | DOJ_CIVIL | $500,000,000 |
Synthes Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
Roussel Uclaf S.A. | Sanofi | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
DePuy Orthopaedics Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2012 | MULTI-AG | $90,000,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2019 | MULTI-AG | $120,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2017 | MULTI-AG | $33,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
Merck | Merck | drug or medical equipment safety violation | 2013 | PA-AG | $8,250,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
Pfizer, Inc. | Pfizer | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
Purdue Pharma | Purdue Pharma | drug or medical equipment safety violation | 2015 | KY-AG | $24,000,000 |
Ranbaxy | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
Ranbaxy Laboratories | Sun Pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2019 | MULTI-AG | $116,860,000 |
Wyeth-Ayerst Laboratories Division | Pfizer | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
Pfizer Inc. | Pfizer | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
St. Jude Medical Inc. | Abbott Laboratories | drug or medical equipment safety violation | 2021 | DOJ_CIVIL | $27,000,000 |
Janssen Pharmaceuticals | Johnson & Johnson | drug or medical equipment safety violation | 2019 | private lawsuit-federal | $387,500,000 |
Organon USA Inc. | Organon & Co. | drug or medical equipment safety violation | 2018 | private lawsuit-federal | $100,000,000 |
Endo International PLC | Endo International | drug or medical equipment safety violation | 2017 | private lawsuit-federal | $775,000,000 |
Takeda Pharmaceutical Co. Ltd. | Takeda Pharmaceutical | drug or medical equipment safety violation | 2015 | private lawsuit-federal | $2,400,000,000 |
Boehringer Ingelheim International | Boehringer Ingelheim | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $650,000,000 |
Endo International PLC | Endo International | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $830,000,000 |
Merck | Merck | drug or medical equipment safety violation | 2014 | private lawsuit-federal | $27,700,000 |
DePuy Orthopaedics, Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $2,475,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2013 | private lawsuit-federal | $288,000,000 |
AstraZeneca | AstraZeneca | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $198,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $770,000,000 |
Merck | Merck | drug or medical equipment safety violation | 2010 | private lawsuit-federal | $41,500,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2009 | private lawsuit-federal | $28,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $745,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2008 | private lawsuit-federal | $40,000,000 |
Merck & Co. | Merck | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $4,850,000,000 |
Eli Lilly and Company | Eli Lilly | drug or medical equipment safety violation | 2007 | private lawsuit-federal | $500,000,000 |
GlaxoSmithKline | GlaxoSmithKline | drug or medical equipment safety violation | 2006 | private lawsuit-state | $63,833,148 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2005 | private lawsuit-federal | $15,000,000 |
Eli Lilly and Company | Eli Lilly | drug or medical equipment safety violation | 2005 | private lawsuit-federal | $690,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2004 | private lawsuit-federal | $90,000,000 |
Pfizer | Pfizer | drug or medical equipment safety violation | 2004 | private lawsuit-federal | $750,000,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $45,000,000 |
American Home Products | Pfizer | drug or medical equipment safety violation | 2002 | private lawsuit-federal | $3,750,000,000 |
Johnson and Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2023 | CA-AG | $302,000,000 |
Endo Health Solutions Inc. | Endo International | drug or medical equipment safety violation | 2024 | DOJ_CIVIL | $464,900,000 |
Mallinckrodt LLC | Mallinckrodt | Controlled Substances Act violation | 2017 | DEA | $35,000,000 |
Johnson & Johnson | Johnson & Johnson | Controlled Substances Act violation | 2008 | USAO | $511,000 |
Anda | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Purdue Frederick Company, Inc. and Purdue Pharma, L.P. | Purdue Pharma | Controlled Substances Act violation | 2007 | NV-AG | $1,047,787 |
Purdue Pharma | Purdue Pharma | Controlled Substances Act violation | 2019 | OK-AG | $270,000,000 |
Purdue Pharma, L.P. | Purdue Pharma | Controlled Substances Act violation | 2015 | NY-AG | $75,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2019 | OK-AG | $85,000,000 |
Mallinckrodt | Mallinckrodt | Controlled Substances Act violation | 2020 | MULTI-AG | $1,600,000,000 |
Endo Pharmaceuticals | Endo International | Controlled Substances Act violation | 2020 | OK-AG | $8,750,000 |
Mylan Laboratories, Inc. | Viatris | consumer protection violation | 2000 | FTC | $100,000,000 |
Abbott Laboratories | Abbott Laboratories | consumer protection violation | 2018 | NY-AG | $50,000 |
Abbott Laboratories, Inc. | Abbott Laboratories | consumer protection violation | 2013 | NY-AG | $25,000 |
AstraZeneca | AstraZeneca | consumer protection violation | 2010 | KY-AG | $5,391,000 |
Biogen Idec Inc. | Biogen | consumer protection violation | 2007 | VT-AG | $10,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Cephalon | Teva Pharmaceutical Industries | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
Endo Pharmaceuticals | Endo International | consumer protection violation | 2019 | CA-AG | $760,000 |
General Nutrition Corp. | Harbin Pharmaceutical Group | consumer protection violation | 2002 | FL-AG | $1,000,000 |
Johnson and Johnson | Johnson & Johnson | consumer protection violation | 2009 | WV-AG | $4,475,000 |
Knoll Pharmaceuticals | AbbVie | consumer protection violation | 2001 | AR-AG | $826,957 |
McNeil-PPC Inc. | Johnson & Johnson | consumer protection violation | 2015 | AL-AG | $500,000 |
McNeil-PPC, Inc. | Johnson & Johnson | consumer protection violation | 2004 | NY-AG | $52,000 |
Merck & Co. Inc. | Merck | consumer protection violation | 2009 | MULTI-AG | $5,400,000 |